The 72nd Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery

The effect of sleep deprivation on endothelial function and inflammation

Achihude Bendet Manar Harmashi Jonathane Lellouche Ina Avidan Ori Hanuka Arnon Blum
Medicine, Ariel University, Laniado Hospital, Israel

Epidemiological studies demonstrated an association between sleep deprivation (SD) and ischemic heart disease, heart failure, hypertension, new onset type 2 diabetes mellitus and metabolic syndrome. Our aim was to find the effect of SD on endothelial function and on the inflammatory profile of young men following SD. Methods: Fourteen healthy (31.3 ± 2.4 years old) men, smokers, took part. All work in the hospital and are doing moon shifts twice a week for more than 12 months. Measurements of the endothelial function were done (fasting) early in the morning (8:00-8:30 AM), using a linear array high resolution ultrasound (12-15 MHz). Cytokines (interleukin 1 [IL-1] and interleukin 6 [IL-6]) were measured in saliva. Saliva was collected in 50 ml tubes, frozen and stored at – 800C until biochemical analysis. IL-1 and IL-6 in saliva were measured using a commercial ELISA kit. Results: All the parameters that were monitored after SD were compared to the baseline measurements. Basic FMD% was 6.7 ± 6.8%, and the post SD FMD% was 1.7± 3.3% (p=0.009). There was a 5.0 ± 6.1% decrease in endothelial function. IL-1 levels increased after SD from 36 ± 21 pg/mL to 47 ± 24 pg/mL (p=0.004), and IL-6 levels increased from 22 ± 07 pg/mL to 36 ± 11 pg/mL (p=0.0005). A negative correlation was found between the decrease in FMD% and the increase in IL-1 level (r=-0.813; p=0.001). A negative correlation was also found between the decrease in FMD% and the increase in IL-6 level (r=-0.735; p=0.003). Discussion: SD caused endothelial dysfunction with increase in markers of inflammation (IL-1 and IL-6), with an inverse correlation between the change (decrease) in endothelial function and the change (increase) in IL-1 and in IL-6. We suggest that SD enhances the inflammatory system, and the activated inflammatory system leads to impaired endothelial function.